Skip to main content
SpringerLink
Log in

Surgery for Stage IV Melanoma

  • Chapter
  • First Online:
Practical Manual for Dermatologic and Surgical Melanoma Management

  • 388 Accesses

Abstract

Although metastatic melanoma was historically associated with poor response to systemic therapy, limited surgical options, and an overall grim prognosis, advances over the past decade have resulted in a dramatic shift in the availability and effectiveness of treatments for these patients. In particular, the development of immune checkpoint inhibitors and targeted therapy has offered many melanoma patients with advanced disease a chance for improved survival and even, in some cases, cure. Importantly, these improvements in systemic therapy have created more potential candidates for surgery at more advanced stages, both for palliative and curative intent. However, given the complex considerations for patients with stage IV melanoma, a multi-disciplinary approach and appropriate patient selection for metastasectomy is critical in order to provide these patients with optimal outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.

    Article  PubMed  Google Scholar 

  2. Rueth NM, Cromwell KD, Cormier JN. Long-term follow-up for melanoma patients: is there any evidence of a benefit? Surg Oncol Clin N Am. 2015;24:359–77.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Harada K, Mizrak Kaya D, Shimodaira Y, et al. Translating genomic profiling to gastrointestinal cancer treatment. Future Oncol. 2017;13:919–34.

    Article  CAS  PubMed  Google Scholar 

  4. Gershenwald JE, Scolyer RA. Melanoma staging: American Joint Committee on Cancer (AJCC) 8th edition and beyond. Ann Surg Oncol. 2018;25:2105–10.

    Article  PubMed  Google Scholar 

  5. Ollila DW, Caudle AS. Surgical management of distant metastases. Surg Oncol Clin N Am. 2006;15:385–98.

    Article  PubMed  Google Scholar 

  6. Tyrell R, Antia C, Stanley S, Deutsch GB. Surgical resection of metastatic melanoma in the era of immunotherapy and targeted therapy. Melanoma Manag. 2017;4:61–8.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bhatia S, Thompson JA. Systemic therapy for metastatic melanoma in 2012: dawn of a new era. J Natl Compr Cancer Netw. 2012;10:403–12.

    Article  CAS  Google Scholar 

  8. Chapman PB, Einhorn LH, Meyers ML, et al. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol. 1999;17:2745–51.

    Article  CAS  PubMed  Google Scholar 

  9. Atkins MB, Kunkel L, Sznol M, Rosenberg SA. High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update. Cancer J Sci Am. 2000;6(Suppl 1):S11–4.

    PubMed  Google Scholar 

  10. Sosman JA, Moon J, Tuthill RJ, et al. A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430. Cancer. 2011;117:4740–06.

    Article  PubMed  Google Scholar 

  11. Markowitz JS, Cosimi LA, Carey RW, et al. Prognosis after initial recurrence of cutaneous melanoma. Arch Surg. 1991;126:703–7; discussion 707–8.

    Article  CAS  PubMed  Google Scholar 

  12. Gadd MA, Coit DG. Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg. 1992;127:1412–6.

    Article  CAS  PubMed  Google Scholar 

  13. Barth A, Wanek LA, Morton DL. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg. 1995;181:193–201.

    CAS  PubMed  Google Scholar 

  14. Eton O, Legha SS, Moon TE, et al. Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol. 1998;16:1103–11.

    Article  CAS  PubMed  Google Scholar 

  15. Meyer T, Merkel S, Goehl J, Hohenberger W. Surgical therapy for distant metastases of malignant melanoma. Cancer. 2000;89:1983–91.

    Article  CAS  PubMed  Google Scholar 

  16. Karp NS, Boyd A, DePan HJ, et al. Thoracotomy for metastatic malignant melanoma of the lung. Surgery. 1990;107:256–61.

    CAS  PubMed  Google Scholar 

  17. Gorenstein LA, Putnam JB, Natarajan G, et al. Improved survival after resection of pulmonary metastases from malignant melanoma. Ann Thorac Surg. 1991;52:204–10.

    Article  CAS  PubMed  Google Scholar 

  18. Harpole DH Jr, Johnson CM, Wolfe WG, et al. Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg. 1992;103:743–8; discussion 748–50.

    Article  PubMed  Google Scholar 

  19. Karakousis CP, Velez A, Driscoll DL, Takita H. Metastasectomy in malignant melanoma. Surgery. 1994;115:295–302.

    CAS  PubMed  Google Scholar 

  20. Tafra L, Dale PS, Wanek LA, et al. Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax. J Thorac Cardiovasc Surg. 1995;110:119–28; discussion 129.

    Article  CAS  PubMed  Google Scholar 

  21. La Hei E, Thompson J, McCaughan B, et al. Surgical resection of pulmonary metastatic melanoma: a review of 83 thoracotomies. Asia Pacific Heart J. 1996;5:111–4.

    Article  Google Scholar 

  22. Ollila DW, Stern SL, Morton DL. Tumor doubling time: a selection factor for pulmonary resection of metastatic melanoma. J Surg Oncol. 1998;69:206–11.

    Article  CAS  PubMed  Google Scholar 

  23. Leo F, Cagini L, Rocmans P, et al. Lung metastases from melanoma: when is surgical treatment warranted? Br J Cancer. 2000;83:569–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Andrews S, Robinson L, Cantor A, DeConti RC. Survival after surgical resection of isolated pulmonary metastases from malignant melanoma. Cancer Control. 2006;13:218–23.

    Article  PubMed  Google Scholar 

  25. Petersen RP, Hanish SI, Haney JC, et al. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg. 2007;133:104–10.

    Article  PubMed  Google Scholar 

  26. Neuman HB, Patel A, Hanlon C, et al. Stage-IV melanoma and pulmonary metastases: factors predictive of survival. Ann Surg Oncol. 2007;14:2847–53.

    Article  PubMed  Google Scholar 

  27. Ricaniadis N, Konstadoulakis MM, Walsh D, Karakousis CP. Gastrointestinal metastases from malignant melanoma. Surg Oncol. 1995;4:105–10.

    Article  CAS  PubMed  Google Scholar 

  28. Ollila DW, Essner R, Wanek LA, Morton DL. Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg. 1996;131:975–9; 979–80.

    Article  CAS  PubMed  Google Scholar 

  29. Haigh PI, Essner R, Wardlaw JC, et al. Long-term survival after complete resection of melanoma metastatic to the adrenal gland. Ann Surg Oncol. 1999;6:633–9.

    Article  CAS  PubMed  Google Scholar 

  30. Agrawal S, Yao TJ, Coit DG. Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol. 1999;6:336–44.

    Article  CAS  PubMed  Google Scholar 

  31. Wood TF, DiFronzo LA, Rose DM, et al. Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival? Ann Surg Oncol. 2001;8:658–62.

    Article  CAS  PubMed  Google Scholar 

  32. Rose DM, Essner R, Hughes TM, et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg. 2001;136:950–5.

    Article  CAS  PubMed  Google Scholar 

  33. Collinson FJ, Lam TK, Bruijn WM, et al. Long-term survival and occasional regression of distant melanoma metastases after adrenal metastasectomy. Ann Surg Oncol. 2008;15:1741–9.

    Article  CAS  PubMed  Google Scholar 

  34. Reddy S, Wolfgang CL. The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol. 2009;10:287–93.

    Article  PubMed  Google Scholar 

  35. Fife KM, Colman MH, Stevens GN, et al. Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol. 2004;22:1293–300.

    Article  CAS  PubMed  Google Scholar 

  36. Fletcher WS, Pommier RF, Lum S, Wilmarth TJ. Surgical treatment of metastatic melanoma. Am J Surg. 1998;175:413–7.

    Article  CAS  PubMed  Google Scholar 

  37. Howard JH, Thompson JF, Mozzillo N, et al. Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). Ann Surg Oncol. 2012;19:2547–55.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Faries MB, Mozzillo N, Kashani-Sabet M, et al. Long-term survival after complete surgical resection and adjuvant immunotherapy for distant melanoma metastases. Ann Surg Oncol. 2017;24:3991–4000.

    Article  PubMed  Google Scholar 

  39. Wolchok JD, Chiarion-Sileni V, Gonzalez R, et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med. 2017;377:1345–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Sosman JA, Kim KB, Schuchter L, et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med. 2012;366:707–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Larkin J, Ascierto PA, Dreno B, et al. Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. N Engl J Med. 2014;371:1867–76.

    Article  PubMed  CAS  Google Scholar 

  42. Faries MB, Leung A, Morton DL, et al. A 20-year experience of hepatic resection for melanoma: is there an expanding role? J Am Coll Surg. 2014;219:62–8.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Deutsch GB, Flaherty DC, Kirchoff DD, et al. Association of surgical treatment, systemic therapy, and survival in patients with abdominal visceral melanoma metastases, 1965–2014: relevance of surgical cure in the era of modern systemic therapy. JAMA Surg. 2017;152:672–8.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Hanna TP, Nguyen P, Baetz T, et al. A population-based study of survival impact of new targeted and immune-based therapies for metastatic or unresectable melanoma. Clin Oncol (R Coll Radiol). 2018;30:609–17.

    Article  CAS  Google Scholar 

  45. Smith MJF, Smith HG, Joshi K, et al. The impact of effective systemic therapies on surgery for stage IV melanoma. Eur J Cancer. 2018;103:24–31.

    Article  CAS  PubMed  Google Scholar 

  46. Bello DM, Panageas KS, Hollmann T, et al. Survival outcomes after metastasectomy in melanoma patients categorized by response to checkpoint blockade. Ann Surg Oncol. 2019. https://doi.org/10.1245/s10434-019-08099-9. [Epub ahead of print].

  47. Aubin JM, Rekman J, Vandenbroucke-Menu F, et al. Systematic review and meta-analysis of liver resection for metastatic melanoma. Br J Surg. 2013;100:1138–47.

    Article  PubMed  Google Scholar 

  48. Deutsch GB, Kirchoff DD, Faries MB. Metastasectomy for stage IV melanoma. Surg Oncol Clin N Am. 2015;24:279–98.

    Article  PubMed  Google Scholar 

  49. Lasithiotakis K, Zoras O. Metastasectomy in cutaneous melanoma. Eur J Surg Oncol. 2017;43:572–80.

    Article  CAS  PubMed  Google Scholar 

  50. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–206.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:472–92.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Reddy S, Han D. Surgical management of distant organ metastases. In: Kluger H, Ariyan S, editors. The melanoma handbook. New York: Elsevier; 2014.

    Google Scholar 

  53. Wei IH, Healy MA, Wong SL. Surgical treatment options for stage IV melanoma. Surg Clin North Am. 2014;94:1075–89. ix

    Article  PubMed  Google Scholar 

  54. Martinez SR, Young SE. A rational surgical approach to the treatment of distant melanoma metastases. Cancer Treat Rev. 2008;34:614–20.

    Article  PubMed  Google Scholar 

  55. Sanki A, Kam PC, Thompson JF. Long-term results of hyperthermic, isolated limb perfusion for melanoma: a reflection of tumor biology. Ann Surg. 2007;245:591–6.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Chua TC, Scolyer RA, Kennedy CW, et al. Surgical management of melanoma lung metastasis: an analysis of survival outcomes in 292 consecutive patients. Ann Surg Oncol. 2012;19:1774–81.

    Article  PubMed  Google Scholar 

  57. Hanna TP, Chauvin C, Miao Q, et al. Clinical outcomes after pulmonary metastasectomy for melanoma: a population-based study. Ann Thorac Surg. 2018;106:1675–81.

    Article  PubMed  Google Scholar 

  58. Guerrini GP, Lo Faso F, Vagliasindi A, et al. The role of minimally invasive surgery in the treatment of lung metastases. J Investig Surg. 2017;30:110–5.

    Article  Google Scholar 

  59. Leiter U, Meier F, Schittek B, Garbe C. The natural course of cutaneous melanoma. J Surg Oncol. 2004;86:172–8.

    Article  PubMed  Google Scholar 

  60. Pawlik TM, Zorzi D, Abdalla EK, et al. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol. 2006;13:712–20.

    Article  PubMed  Google Scholar 

  61. Han D, Beasley GM, Tyler DS, Zager JS. Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusion. Expert Opin Drug Metab Toxicol. 2011;7:1383–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Hughes MS, Zager J, Faries M, et al. Results of a randomized controlled multicenter phase III trial of percutaneous hepatic perfusion compared with best available care for patients with melanoma liver metastases. Ann Surg Oncol. 2016;23:1309–19.

    Article  PubMed  Google Scholar 

  63. Goldinger SM, Panje C, Nathan P. Treatment of melanoma brain metastases. Curr Opin Oncol. 2016;28:159–65.

    Article  CAS  PubMed  Google Scholar 

  64. Ray S, Dacosta-Byfield S, Ganguli A, et al. Comparative analysis of survival, treatment, cost and resource use among patients newly diagnosed with brain metastasis by initial primary cancer. J Neuro-Oncol. 2013;114:117–25.

    Article  Google Scholar 

  65. Tawbi HA, Forsyth PA, Algazi A, et al. Combined nivolumab and ipilimumab in melanoma metastatic to the brain. N Engl J Med. 2018;379:722–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. McWilliams RR, Brown PD, Buckner JC, et al. Treatment of brain metastases from melanoma. Mayo Clin Proc. 2003;78:1529–36.

    Article  PubMed  Google Scholar 

  67. Pinkham MB, Sahgal A, Pullar AP, Foote MC. In response to Fogarty et al. and why adjuvant whole brain radiotherapy is not recommended routinely. BMC Cancer. 2017;17:768.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Lonser RR, Song DK, Klapper J, et al. Surgical management of melanoma brain metastases in patients treated with immunotherapy. J Neurosurg. 2011;115:30–6.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Eigentler TK, Figl A, Krex D, et al. Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer. 2011;117:1697–703.

    Article  PubMed  Google Scholar 

  70. Sahgal A, Larson D, Knisely J. Stereotactic radiosurgery alone for brain metastases. Lancet Oncol. 2015;16:249–50.

    Article  PubMed  Google Scholar 

  71. Klemen ND, Feingold PL, Goff SL, et al. Metastasectomy following immunotherapy with adoptive cell transfer for patients with advanced melanoma. Ann Surg Oncol. 2017;24:135–41.

    Article  PubMed  Google Scholar 

  72. Mavor ME, Richardson H, Miao Q, et al. Disparities in diagnosis of advanced melanoma: a population-based cohort study. CMAJ Open. 2018;6:E502–12.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Conflict of Interest

The authors declare that they have no financial conflicts of interest relevant to this work.

Author information

Authors and Affiliations

  1. Section of Surgical Oncology, Department of Surgery, Yale School of Medicine, New Haven, CT, USA

    Norman G. Nicolson

  2. Division of Surgical Oncology, Department of Surgery, Oregon Health & Science University, Portland, OR, USA

    Dale Han

Authors
  1. Norman G. Nicolson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dale Han
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dale Han .

Editor information

Editors and Affiliations

  1. Division of Dermatology, Department of Medicine, Harbor-UCLA Medical Center, Torrance, CA, USA

    Delphine J. Lee

  2. Cedars-Sinai Medical Center, The Angeles Clinic and Research Institute, Los Angeles, CA, USA

    Mark B. Faries

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nicolson, N.G., Han, D. (2021). Surgery for Stage IV Melanoma. In: Lee, D., Faries, M. (eds) Practical Manual for Dermatologic and Surgical Melanoma Management. Springer, Cham. https://doi.org/10.1007/978-3-030-27400-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-27400-9_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-27399-6

  • Online ISBN: 978-3-030-27400-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation